Home / Anastrozole / Czechia
CZ ATC L02BG03 · updated 2 Nov 2026
Anastrozole shortage in Czechia
Is there an Anastrozole shortage in Czechia?
Yes. As of 2 Nov 2026, 4 Anastrozole products are reported short in Czechia, the first since 14 May 2026. The company estimate for the return is 1 Dec 2026 (latest 1 Dec 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Ireland. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ALOZEX 1MG 1MG TBL FLM 100 | Glenmark Pharmaceuticals s.r.o., Praha | 14 May 2026 | 1 Dec 2027 | Manufacturing problem Výrobní důvody |
| CZ | ANAPREX 1MG 1MG TBL FLM 100 | PHARMAGEN CZ s.r.o., Praha | 2 Nov 2026 | 1 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | ANAPREX 1MG 1MG TBL FLM 28 | PHARMAGEN CZ s.r.o., Praha | 2 Nov 2026 | 1 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | ANASTROZOL TEVA 1MG 1MG TBL FLM 30 anticipated | Teva Pharmaceuticals CR, s.r.o., Praha | 24 Nov 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.